Clinical Cases in Pharmacology Clinical Cases  ·  Psychiatry IV  ·  Neurocognitive Disorders  ·  Haloperidol for Hospital Delirium: A Reflex the Largest Trial Didn't Support
Psychiatry IV, Case 0006 — Neurocognitive Disorders

Haloperidol for Hospital Delirium: A Reflex the Largest Trial Didn't Support

An agitated, delirious inpatient is pulling at his IV lines. The order for haloperidol is nearly automatic — the disagreement is whether the largest trial ever run on this exact practice changes what "automatic" should mean.

Abbreviations, terms, and other agents mentioned in this case CAM — Confusion Assessment Method, a bedside delirium screening tool  ·  EPS — extrapyramidal symptoms  ·  PADIS — Pain, Agitation/sedation, Delirium, Immobility, and Sleep disruption — the 2018 SCCM clinical practice guideline
Presentation

Robert N., 74, retired firefighter, was admitted three days ago for a urinary tract infection that has since been appropriately treated with antibiotics, and he was oriented and pleasant on admission. He still coaches a youth flag-football team on weekends and lives independently with his wife, and aside from well-controlled hypertension and a hip replacement two years ago, he has no significant medical history — certainly no prior cognitive impairment. Overnight he became acutely confused — not recognizing the nurse he'd joked with the evening before, trying repeatedly to climb out of bed convinced he was late for a shift, and pulling at his IV line hard enough that it infiltrated once already tonight. His daughter, reached by phone, says he was completely himself two days ago, sharp enough to needle her about a fantasy football trade.

The CAM screen is positive for delirium, hyperactive subtype, and the working differential covers the usual hospital-delirium contributors — the resolving infection itself, sleep disruption from overnight vitals and lab draws, a new opioid started for a hip injury sustained during a fall risk assessment two days ago, and simple disorientation from an unfamiliar environment. None of those contributors has yet been addressed tonight; the acute problem in front of the team is behavioral, not diagnostic. The night resident's reflex, watching him try to climb over the bed rail for the third time in an hour, is to order haloperidol — the most familiar tool on the floor for exactly this scenario, ordered here almost as often as it's questioned.

Robert N. · 74 Acute Hyperactive Delirium
History
No baseline cognitive impairment; admitted for UTI, now appropriately treated
Onset
Acute confusion overnight, CAM-positive, hyperactive subtype
Behavior
Repeated attempts to climb out of bed; one IV line pulled and infiltrated
Contributing factors
New opioid ×2 days for hip pain; overnight sleep disruption from vitals/labs
Cardiac
No baseline QT prolongation; no other QT-prolonging medications on his list
Safety
Fall risk elevated; at risk of line removal and injury without intervention

At the bedside, on the medical floor

Hospitalist Opening

I want to order haloperidol tonight, low dose. He's pulled one line already and he's trying to climb the bed rail. I'm not trying to fix his delirium with this — I'm trying to get through the next four hours without an injury or another infiltrated IV.

Clinical Pharmacologist Response

I want to name what the evidence actually shows before we default to that. MIND-USA — Girard and colleagues, New England Journal of Medicine, 2018, 566 delirious ICU patients randomized to haloperidol, ziprasidone, or placebo — found no significant difference between any group in days alive without delirium or coma, and no difference in 90-day survival. This is the largest, most rigorous trial ever run on this exact question, and it found the drug doesn't do what we usually assume it does.

I take the safety concern seriously, but I'd push back on reaching for haloperidol as though it's known to help here — the trial evidence says it specifically doesn't shorten the delirium itself, which is different from what's actually being asked for right now.

Geriatric Psychiatrist Final

I think you're both right, about different things. MIND-USA is real and it means we shouldn't tell ourselves haloperidol is treating his delirium — it isn't, by the best evidence we have. But there's a real difference between that claim and tonight's actual question, which is narrower: does he need something for the next few hours to prevent an injury.

The PADIS guideline from the Society of Critical Care Medicine, 2018, is explicit that non-pharmacologic measures — reorientation, minimizing overnight disruption, a sitter if one is available — come first. Given how close we already are to an injury tonight, I'd support a single low dose as a bridge while we get a sitter arranged, with a hard stop on repeat dosing without reassessment.

Regimen selected
Haloperidol
Antipsychotic · Single low dose (0.5 mg), acute safety indication only
Used narrowly as a bridge to prevent imminent injury while a sitter is arranged, explicitly not framed as delirium treatment per the trial evidence.
1:1 Sitter
Non-Pharmacologic Safety Measure · Arranged overnight
The actual first-line intervention per PADIS guidance; haloperidol is a bridge until this is in place, not a substitute for it.
Opioid Reassessment
Medication Review · Ongoing
The opioid started two days ago for hip pain is reviewed as a possible contributor; alternative non-opioid analgesia considered if pain control allows.
Repeat/Scheduled Antipsychotic Dosing — Ruled Out
Considered, not adopted
Explicitly rejected; any further dose requires fresh reassessment rather than a standing order, given the trial evidence against ongoing use.
Where this was left

Agreed: a single low dose of haloperidol given tonight as a bridge, a 1:1 sitter arranged for the remainder of the night, and the recently started opioid reviewed for alternatives. No standing or repeat antipsychotic order is placed; any further dosing requires a fresh bedside reassessment.

Not agreed: whether tonight's single dose, even bridged and time-limited, risks becoming exactly the kind of reflexive practice the pharmacologist wants to move the floor away from. The hospitalist views a clearly-bounded, safety-specific exception as compatible with that goal; the pharmacologist worries that any use, however narrowly framed tonight, makes the next night's order easier to write without the same scrutiny.

Educational content only — a composite teaching case, not a real patient encounter or a substitute for clinical guidance. About These Cases →